Update meta-analysis on the efficacy and safety issues of fexofenadine

BACKGROUND: Fexofenadine emerged as one of the most representative second generation histamine H1 antagonist drugs since the 1990s, with an outstanding efficacy and appreciable safety for the treatment of allergic patients. While allergic rhino-conjunctivitis represents the most frequent atopic dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez, René Maximiliano, Moreno, Pablo, Compalati, Enrico, Canonica, Giorgio Walter, Ansotegui Zubeldia, Ignacio Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401337/
https://www.ncbi.nlm.nih.gov/pubmed/37546236
http://dx.doi.org/10.1016/j.waojou.2023.100795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401337/
https://www.ncbi.nlm.nih.gov/pubmed/37546236
http://dx.doi.org/10.1016/j.waojou.2023.100795

Ejemplares similares